GRAIL, Inc. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
GRAIL, Inc. (GRAL) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of -$33.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- GRAIL, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was -$33.00K, a 105.18% decline year-over-year.
- GRAIL, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was -$782.00K, a 463.72% decline year-over-year.
- GRAIL, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $153.00K, a 80.88% decline year-over-year.
- GRAIL, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-06-30 was $637.00K, a 71.24% increase year-over-year.
- GRAIL, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was $1.20M, a 212.73% increase from fiscal 2024.
- GRAIL, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $385.00K, a 123.84% increase from fiscal 2023.
- GRAIL, Inc. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was $172.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$33.00K 10-Q · filed 2026-08-06 | -$815.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2026-03-31 | -$782.00K 10-Q · filed 2026-08-06 | |||
| 2025-12-31 | $1.20M 10-K · filed 2026-03-12 | |||
| 2025-09-30 | $153.00K 10-Q · filed 2025-11-13 | $790.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.00M derived: sum of 3 quarters · filed 2026-08-06 | |
| 2025-06-30 | $637.00K 10-Q · filed 2026-08-06 | $852.00K derived: sum of 2 quarters · filed 2026-08-06 | ||
| 2025-03-31 | $215.00K 10-Q · filed 2026-08-06 | |||
| 2024-12-31 | $385.00K 10-K · filed 2026-03-12 | |||
| 2024-09-30 | $800.00K 10-Q · filed 2025-11-13 | $1.17M derived: sum of 2 quarters · filed 2025-11-13 | $1.12M derived: sum of 3 quarters · filed 2025-11-13 | |
| 2024-06-30 | $372.00K 10-Q · filed 2025-11-13 | $320.00K derived: sum of 2 quarters · filed 2025-11-13 | ||
| 2024-03-31 | -$52.00K 10-Q · filed 2025-11-13 | |||
| 2023-12-31 | $172.00K 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |